angiotensin ii has been researched along with 8-epi-prostaglandin f2alpha in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 9 (36.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzales, N; Lanting, L; Nadler, J; Natarajan, R | 1 |
| Grobuschek, T; Hammer-Kogler, S; Juan, H; Sametz, W; Wintersteiger, R | 1 |
| Bolterman, RJ; Haas, JA; Juncos, LA; Krier, JD; Romero, JC | 1 |
| Crkovská, J; Jirsa, M; Seráková, M; Stípek, S; Tesar, V; Vernerová, Z; Zima, T | 2 |
| Cheng, ZJ; Fiebeler, A; Ganten, D; Ganten, U; Lapatto, R; Luft, FC; Mervaala, EM; Müller, DN; Nurminen, K; Tikkanen, I; Vapaatalo, H | 1 |
| Aizawa, T; Ishizaka, N; Nagai, R; Ohashi, N; Ohno, M; Usui, S | 1 |
| Imai, E; Karber, A; Kawada, N; Welch, WJ; Wilcox, CS | 1 |
| Arosio, E; Bencini, C; Capone, ML; Degan, M; Del Vecchio, C; Gaino, S; Lechi, A; Mansueto, G; Menapace, L; Minuz, P; Morganti, A; Palatresi, S; Patrignani, P; Patrono, C; Santonastaso, CL; Seta, F; Tacconelli, S; Tommasoli, R | 1 |
| Abukhalaf, IK; Bayorh, MA; Eatman, D; Ganafa, AA; Silvestrov, N; Socci, RR | 1 |
| Cheng, ZJ; Finckenberg, P; Helkamaa, T; Lapatto, R; Louhelainen, M; Luft, FC; Männistö, P; Merasto, S; Mervaala, EM; Müller, DN; Rauhala, P; Reenilä, I | 1 |
| Cassis, LA; Daugherty, A; Dellsperger, KC; Gavrila, D; Li, WG; McCormick, ML; Miller, FJ; Oberley, LW; Thomas, M; Weintraub, NL | 1 |
| Majid, DS; Pech, V; Sikka, SC; Sindhu, RK; Vaziri, ND | 1 |
| Berge, RK; Gudbrandsen, OA; Hultstrøm, M; Iversen, BM; Leh, S; Monica Bivol, L; Vågnes, Ø | 1 |
| Elmarakby, AA; Imig, JD; Pollock, DM; Pollock, JS; Williams, JM | 1 |
| Hercule, H; Newaz, M; Oyekan, A; Truong, L; Yousefipour, Z | 1 |
| Castillo, A; Islam, MT; Khan, MA; Majid, DS | 1 |
| Carretero, OA; Liao, TD; Liu, TS; Peng, H; Reudelhuber, TL; Shesely, EG; Xu, J; Yang, JJ; Yang, XP | 1 |
| Antonioli, L; Aydinoglu, F; Bernardini, N; Blandizzi, C; Colucci, R; Duranti, E; Fornai, M; Ippolito, C; Neves, MF; Rugani, I; Solini, A; Taddei, S; Virdis, A | 1 |
| Denton, KM; Eppel, GA; Evans, RG; Head, GA | 1 |
| Bloch, W; Brixius, K; Reuter, H; Schwinger, RH; Streit, U; Wahlers, T | 1 |
| Cheng, GJ; Hu, GY; Huang, L; Mei, WJ; Peng, ZZ; Qin, J; Tao, LJ; Xie, YY; Yuan, QJ; Yuan, XN | 1 |
| Chen, J; Hu, X; Jiang, H; Lu, Z; Xu, C; Zhang, J; Zhou, X | 1 |
| Inoue, T; Ishii, N; Miyazaki, T; Nishiyama, A; Ohno, Y; Suzuki, H; Takenaka, T | 1 |
| Baylis, C; Cunningham, MW; Sasser, JM | 1 |
1 trial(s) available for angiotensin ii and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease.
Topics: Adolescent; Adult; Aged; Angioplasty; Angiotensin II; Antioxidants; Biomarkers; Blood Glucose; Cholesterol; Cross-Sectional Studies; Dinoprost; F2-Isoprostanes; Female; Homocysteine; Humans; Hypertension; Hypertension, Renovascular; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Platelet Activation; Reference Values; Renal Artery Obstruction; Renin; Renin-Angiotensin System; Thromboxane B2; Triglycerides; Vitamins | 2002 |
24 other study(ies) available for angiotensin ii and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors.
Topics: Angiotensin II; Animals; Antioxidants; Cell Division; Cells, Cultured; Dinoprost; F2-Isoprostanes; Glucose; Growth Substances; Muscle, Smooth, Vascular; Phospholipases A; Platelet-Derived Growth Factor; Pyrrolidines; Quinacrine; Swine; Thiocarbamates; Time Factors; Transforming Growth Factor beta | 1996 |
Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dinoprost; Dose-Response Relationship, Drug; Drug Interactions; Ear; F2-Isoprostanes; Fatty Acids, Unsaturated; Female; Hydrazines; Male; Norepinephrine; Perfusion; Prostaglandins; Rabbits; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Low-dose angiotensin II increases free isoprostane levels in plasma.
Topics: Angiotensin II; Animals; Blood Pressure; Dinoprost; F2-Isoprostanes; Female; Oxidative Stress; Swine; Vasoconstrictor Agents | 1999 |
[Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Doxorubicin; Eicosanoids; Enalapril; F2-Isoprostanes; Losartan; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar | 1999 |
Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes.
Topics: Acetylcholine; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Dinoprost; Disease Models, Animal; Endothelium, Vascular; F2-Isoprostanes; Humans; Hypertension; Ketone Oxidoreductases; Male; Nitrates; Nitrites; Nitroprusside; Norepinephrine; Rats; Rats, Sprague-Dawley; Renal Artery; Renin; Superoxide Dismutase; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents; Vasodilation | 2001 |
Angiotensin II and catecholamines increase plasma levels of 8-epi-prostaglandin F(2alpha) with different pressor dependencies in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase Inhibitors; Dinoprost; Dose-Response Relationship, Drug; Hypertension; Ibuprofen; Male; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2002 |
Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Enalapril; F2-Isoprostanes; Losartan; Nephrotic Syndrome; Rats | 2002 |
A mouse model of angiotensin II slow pressor response: role of oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Dinoprost; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; F2-Isoprostanes; Infusion Pumps; Kidney; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Spin Labels; Systole; Vasoconstrictor Agents | 2002 |
Effect of losartan on oxidative stress-induced hypertension in Sprague-Dawley rats.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Buthionine Sulfoximine; Cyclic AMP; Cyclic GMP; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Epoprostenol; F2-Isoprostanes; Glutathione; Heart Rate; Hypertension; Kidney; Losartan; Male; Models, Cardiovascular; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Thromboxane A2; Treatment Outcome | 2003 |
Entacapone protects from angiotensin II-induced inflammation and renal injury.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Cardiomegaly; Catechol O-Methyltransferase; Catechols; Creatinine; Dinoprost; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Hypertension; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Leukocytes; Male; Models, Cardiovascular; Nitriles; Norepinephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2003 |
Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Antioxidants; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Blood Pressure; Dinoprost; Hyperlipidemias; Lipids; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Mutant Strains; Osteopontin; Oxidative Stress; Sialoglycoproteins; Vasoconstrictor Agents; Vitamin E | 2005 |
Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets.
Topics: Acetophenones; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Diet, Sodium-Restricted; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Infusions, Intravenous; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Vasoconstrictor Agents | 2006 |
Prevention of hypertension and organ damage in 2-kidney, 1-clip rats by tetradecylthioacetic acid.
Topics: Albuminuria; Angiotensin II; Animals; Blood Vessels; Dinoprost; Fatty Acids; Hypertension, Renovascular; Kidney; Liver; Male; Oleic Acid; Proteinuria; Rats; Rats, Wistar; Renin; RNA, Messenger; Sulfides; Vasoconstrictor Agents | 2006 |
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Bradykinin; Chronic Disease; Cyclic N-Oxides; Dinoprost; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enalapril; Hydrogen Peroxide; Hypertension; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Spin Labels; Superoxides; Time Factors | 2007 |
Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin II; Animals; Creatinine; Dinoprost; Gene Expression; Glycerol; Hypoglycemic Agents; Kidney Glomerulus; Male; Nitric Oxide; Nitrites; PPAR gamma; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Thromboxane A2, Prostaglandin H2; Renal Artery; Sodium; Thiazolidinediones; Thromboxane A2; Thromboxane B2; Vasoconstriction | 2007 |
Attenuation of renal excretory responses to ANG II during inhibition of superoxide dismutase in anesthetized rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Ditiocarb; Diuresis; Enalaprilat; Enzyme Inhibitors; Hemodynamics; Infusions, Intra-Arterial; Kidney; Kidney Cortex; Male; NADPH Oxidases; Nitrates; Nitrites; Rats; Rats, Sprague-Dawley; Renal Circulation; Superoxide Dismutase | 2010 |
Local angiotensin II aggravates cardiac remodeling in hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Collagen; Desoxycorticosterone; Dinoprost; Disease Models, Animal; Heart Rate; Hypertension; Male; Membrane Glycoproteins; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2010 |
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Angiotensin II; Animals; Biomechanical Phenomena; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Collagen Type I; Coronary Vessels; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprost; Elastin; Fatty Acids, Unsaturated; Fibronectins; Humans; Hydrazines; Immunohistochemistry; Male; Mesenteric Arteries; Mice; Mice, Knockout; Pyrazoles; Vascular Resistance | 2012 |
Effects of tempol and candesartan on neural control of the kidney.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Diet; Diet, High-Fat; Dinoprost; Dose-Response Relationship, Drug; Electric Stimulation; Heart Rate; Hematocrit; Kidney; Kidney Function Tests; Male; Obesity; Rabbits; Renal Circulation; Spin Labels; Superoxides; Tetrazoles; Urodynamics | 2012 |
Phosphorylation of myocardial eNOS is altered in patients suffering from type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Diabetes Mellitus, Type 2; Dinoprost; Humans; Middle Aged; Myocardium; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Tyrosine | 2013 |
Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis.
Topics: Angiotensin II; Animals; Antioxidants; Cell Line; Class Ia Phosphatidylinositol 3-Kinase; Collagen Type I; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Kidney Diseases; Kidney Tubules; Lipid Peroxidation; Losartan; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridones; Rats; Rats, Sprague-Dawley; Signal Transduction; Transfection; Ureteral Obstruction | 2013 |
Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Citrus; Coronary Restenosis; Dinoprost; Flavanones; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phytotherapy; Plant Extracts; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor RelA; Tunica Intima | 2013 |
Calcitriol supplementation improves endothelium-dependent vasodilation in rat hypertensive renal injury.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcitriol; Dietary Supplements; Dinoprost; Disease Models, Animal; Endothelium, Vascular; Glucuronidase; Hypertension; Irbesartan; Kidney; Kidney Diseases; Klotho Proteins; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Tetrazoles; Vasodilation; Vitamins | 2014 |
Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Arginine; Arterial Pressure; Dinoprost; Disease Models, Animal; Down-Regulation; Humans; Hypertension; Injections, Subcutaneous; Kidney; Liver; Male; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Proteinuria; Rats, Sprague-Dawley; Recombinant Proteins; Relaxin; Thiobarbituric Acid Reactive Substances | 2014 |